Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The emergence of COVID-19 presented unprecedented challenges to global health, highlighting the critical importance of a robust immune system. In the search for effective treatments, Thymalin Peptide has shown significant promise, particularly in supporting patients with severe forms of the disease. Research suggests that Thymalin, a peptide derived from the thymus gland, can play a vital role in modulating the immune response, which is often dysregulated in severe COVID-19 cases, leading to a 'cytokine storm'.
Clinical studies have investigated the impact of Thymalin Peptide on patients with severe COVID-19. These studies indicate that when administered alongside standard therapy, Thymalin led to more rapid clinical improvements. Patients treated with Thymalin demonstrated better recovery from lymphopenia, faster normalization of inflammatory markers like C-reactive protein and D-dimer, and improved lymphocyte and NK-cell counts. Crucially, Thymalin appeared to halve hospital mortality rates in older patients with severe COVID-19.
The mechanism behind Thymalin's effectiveness in COVID-19 likely stems from its ability to regulate gene expression and immune protein synthesis. The peptides within Thymalin, such as EW, KE, and EDP, are thought to interact with DNA and histones, influencing the production of cytokines and regulating immune cell differentiation. This action helps prevent the development of a cytokine storm, a hyper-inflammatory response that is a major cause of severe illness and mortality in COVID-19 patients.
Furthermore, Thymalin's effects on normalizing the immune status indicators correlate with its known immunoprotective and geroprotective properties. Given that older individuals are more susceptible to severe COVID-19 due to age-related thymic involution, Thymalin offers a potentially valuable therapeutic strategy. The research on Thymalin Peptide in the context of COVID-19 underscores its potential as an effective agent in complex therapeutic strategies for severe respiratory infections, offering hope for improved patient outcomes.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
